US › Healthcare

Envoy Medical Inc. (COCH)

US · Healthcare · Medical Devices

$0.68-4.21%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$51,000

Revenue YoY

-34.6%

Net profit

$-6.0M

EPS

$-0.07

EPS estimate

$-0.09

Net margin

-11,729.4%

EPS came in at -0.07 against a street estimate of -0.09 — a beat of 22.2%.

Key statistics

Market cap

$54.8M

Forward P/E

0.0

P/B

15.32

Book value

$0.05

EPS (TTM)

$-0.74

52-week high

$1.89

52-week low

$0.36

50-day MA

$0.71

200-day MA

$0.70

Beta

1.90

Analyst view

Analysts rate Envoy Medical Inc. a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $2.00.

Shareholding

Insiders

40.23%

Institutions

23.32%

Largest institutional holders

Fund	Stake
Nantahala Capital Management, LLC	9.91%
Bleichroeder LP	8.10%
Vanguard Capital Management, LLC	1.14%
Geode Capital Management, LLC	0.68%
Vanguard Fiduciary Trust Co	0.38%
The Colony Group LLC	0.28%
Arcus Capital Partners LLC	0.24%
Northern Trust Corp	0.14%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Envoy Medical Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.